ResMed/RMD

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About ResMed

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Ticker

RMD

Sector

Healthcare

Trading on

NYSE

Industry

Health Care Equipment and Supplies

Headquarters

San Diego, United States

Employees

10,140

ResMed Metrics

BasicAdvanced
$27B
Market cap
28.76
P/E ratio
$6.50
EPS
0.67
Beta
$1.88
Dividend rate
1.01%
Dividend yield
$27B
0.67
$1.88
3.042
1.393
24.479
25.215
28.85%
23.55%
11.91%
22.39%
28.76
6
5.93
21.23
25.66
1.01%
14.16%
10.91%
14.04%
27.60%
6.42%

What the Analysts think about ResMed

Analyst Ratings

Majority rating from 15 analysts.
Buy

ResMed Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
25.09% profit margin
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$1.2B
2.93%
Net income
$300M
43.87%
Profit margin
25.09%
39.78%

ResMed Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 11.34%
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$1.60
$1.64
$1.88
$2.13
-
Expected
$1.69
$1.62
$1.80
$1.91
$2.06
Surprise
-5.37%
1.42%
4.70%
11.34%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for ResMed stock?

ResMed (RMD) has a market cap of $27B as of July 03, 2024.

What is the P/E ratio for ResMed stock?

The price to earnings (P/E) ratio for ResMed (RMD) stock is 28.76 as of July 03, 2024.

Does ResMed stock pay dividends?

Yes, the ResMed (RMD) stock pays dividends to shareholders. As of July 03, 2024, the dividend rate is $1.88 and the yield is 1.01%. ResMed has a payout ratio of 28.85% on a trailing twelve-month basis.

When is the next ResMed dividend payment date?

The next ResMed (RMD) dividend payment date is unconfirmed.

What is the beta indicator for ResMed?

ResMed (RMD) has a beta rating of 0.67. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell ResMed stock

Buy or sell ResMed stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing